Pharyngoesophageal reconstruction using free jejunal interposition grafts.

Forty patients underwent pharyngoesophageal reconstruction with a free jejunal interposition graft (FJIG). Three categories of disease were treated: (1) primary upper aerodigestive tract carcinomas, (2) recurrent carcinomas, and (3) benign pharyngoesophageal stenosis. There were no intraoperative graft failures. Postoperative complications included four perioperative deaths, eight late graft failures, three transient fistulas, eight distal graft strictures, one prolonged ileus, two postoperative hematomas, one abdominal wound dehiscence, one abdominal abscess, and one hypoglossal nerve palsy. Of the eight patients with late graft failures, three underwent successful jejunal reimplantation, yielding an overall success rate of 88% (35/40). The advantages of an FJIG are as follows: (1) a single-stage procedure for large defects, (2) a jejunal segment approximately the size of the pharyngoesophagus, (3) tissue that is able to tolerate radiation therapy, (4) maintenance of near-physiologic swallowing mechanism, (5) denervated small-bowel model, (6) excellent palliative procedure, and (7) shortened hospitalization. Disadvantages include (1) microvascular surgical technique, (2) abdominal procedure, and (3) limited esophageal speech.
AuthorsS R Fisher, T B Cole, W C Meyers, H F Seigler
JournalArchives of otolaryngology (Chicago, Ill. : 1960) (Arch Otolaryngol) Vol. 111 Issue 11 Pg. 747-52 (Nov 1985) ISSN: 0003-9977 [Print] UNITED STATES
PMID2413833 (Publication Type: Journal Article)
  • Adult
  • Aged
  • Carcinoma, Squamous Cell (surgery)
  • Esophageal Neoplasms (surgery)
  • Esophageal Stenosis (surgery)
  • Esophagoplasty
  • Female
  • Follow-Up Studies
  • Glottis
  • Humans
  • Hypopharyngeal Neoplasms (surgery)
  • Jejunum (transplantation)
  • Laryngeal Neoplasms (surgery)
  • Male
  • Middle Aged
  • Oropharyngeal Neoplasms (surgery)
  • Palliative Care
  • Pharynx (surgery)
  • Postoperative Complications (epidemiology, mortality)
  • Reoperation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: